John A. Scarlett

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Menlo Park, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Scott A. Samuels for John A. Scarlett
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for John A. Scarlett

Form 4 holding Chairman, President and CEO, Director

GERON CORP

Security class
Restricted Stock Units
Shares / value
410,000
Estimated value
$1,868,370
Report date
18 Feb 2025
Price
$4.56
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Chairman, President and CEO, Director

GERON CORP

Security class
Common Stock
Shares / value
125,000
Estimated value
$220,625
Report date
27 Feb 2025
Price
$1.76
Ownership
John A. Scarlett III 1999 Trust
Form 4 holding Chairman, President and CEO, Director

GERON CORP

Security class
Common Stock
Shares / value
12,500
Estimated value
$22,063
Report date
27 Feb 2025
Price
$1.76
Ownership
Direct
Form 4 holding Chairman, President and CEO, Director

GERON CORP

Security class
Stock Option (right to buy)
Shares / value
2,457,000
Estimated value
Report date
18 Feb 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CytomX Therapeutics, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
20,000
Estimated value
Report date
16 Jun 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

CHIASMA, INC

Security class
Common Stock
Shares / value
0
Estimated value
Report date
05 Aug 2021
Price
Ownership
Direct
Form 4 holding Director

CHIASMA, INC

Security class
Stock Option (Right to Buy)
Shares / value
0
Estimated value
Report date
05 Aug 2021
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by John A. Scarlett

4 GERN

GERON CORP

Report period
08 Feb 2023
Transactions
9
Transaction value
-$2,059,133
Accepted by SEC
10 Feb 2023, 20:47
Role
Chairman, President and CEO, Director
Next action
Open filing details
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .